BIOTRONIK Presents World's Broadest Portfolio of Cardiac Devices Approved for MR Scans at Cardiostim 2012
(firmenpresse) - BERLIN -- (Marketwire) -- 06/12/12 -- 's innovative new technology, which for the first time allows implantable cardiac defibrillator () and heart failure patients to undergo life-saving magnetic resonance imaging () scans, is scheduled to be showcased at the 2012, 18th World Congress in Nice, France, from June 13-16.
BIOTRONIK's broad, technologically advanced ProMRI product portfolio, which features the new ICD and pacemaker series, includes 3 ICDs, 2 pacemakers as well as a CRT-D (cardiac resynchronization therapy defibrillator) and a CRT-P (cardiac resynchronization therapy pacemaker) device and more than 16 compatible leads.
, a cardiologist and an expert in diagnostic imaging techniques from Germany's University of Würzburg and a key contributor in the development of BIOTRONIK's MRI-approved technology, will be discussing the devices as well as the relationship between the growing need for MR imaging and cardiac devices during the congress on June 15, at the BIOTRONIK booth.
"It is very important for patients to have access to -- the 'gold standard' for soft tissue imaging and critical for the diagnosis of conditions such as cancer and strokes," commented Professor Bauer. "Patients with standard ICDs, CRT-Ds and CRT-Ps are currently denied access to MRI due to the adverse effects of electromagnetic fields produced by MRI but 50-75% of them will be indicated for an MR scan during the lifetime of their device."
"BIOTRONIK's ProMRI technology is groundbreaking," continued Professor Bauer. "Physicians now have the opportunity to implant an advanced, high quality device that treats life-threatening -- and also allows the use of MRI to diagnose serious comorbidities."
"Since 2003, our products have been in development with a long-term view that MR scans for patients with a cardiac device will be a market requirement in the future," said Christoph Böhmer, Managing Director at BIOTRONIK. "Today this has resulted in BIOTRONIK's ability to deliver the world's first and only MRI-approved , CRT-Ds and , a true milestone in cardiac rhythm management therapy."
As a worldwide scientific congress in the field of electrophysiology and cardiac techniques, Cardiostim 2012 gathers around 6,000 of the most distinguished professionals working in this field worldwide.
As one of the world's leading manufacturers of cardiovascular medical devices, with several million devices implanted, BIOTRONIK is represented in over 100 countries by its global workforce of more than 5,600 employees. Known for having its finger on the pulse of the medical community, BIOTRONIK assesses the challenges physicians face and provides the best solutions for all phases of patient care, ranging from diagnosis to treatment to patient management. Quality, innovation and reliability define BIOTRONIK and its growing success -- and deliver confidence and peace of mind to physicians and their patients worldwide.
Image Available:
Sandy Hathaway
Senior Director, Global Communications
BIOTRONIK SE & Co. KG
Woermannkehre 1
12359 Berlin
Tel. +49 (0) 30 68905 1602
Email:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 12.06.2012 - 13:24 Uhr
Sprache: Deutsch
News-ID 155605
Anzahl Zeichen: 0
contact information:
Town:
BERLIN
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 199 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BIOTRONIK Presents World's Broadest Portfolio of Cardiac Devices Approved for MR Scans at Cardiostim 2012"
steht unter der journalistisch-redaktionellen Verantwortung von
BIOTRONIK SE. Co. KG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
